Telmisartan Impurity 21 | CAS 210113-71-6 - Request Quote
Telmisartan Impurity 21
| SZ CAT No: | SZ-T006051 |
| CAS No | 210113-71-6 |
| Mol.F. | C13H10BrCl |
| Mol.Wt. | 281.6 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Telmisartan Impurity 21 is chemically 4'-(Bromomethyl)-2-chloro-1,1'-biphenyl. Telmisartan Impurity 21 is supplied with detailed characterization data compliant with regulatory guideline. Telmisartan Impurity 21 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Telmisartan.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 210113-71-6
Purchase 210113-71-6
Order 210113-71-6
Enquire 210113-71-6
price of 210113-71-6
210113-71-6 Supplier
210113-71-6 Manufacturer
210113-71-6 Exporter
buy high quality Telmisartan Impurity 21
Purchase Telmisartan Impurity 21
Telmisartan Impurity 21 suppliers
Telmisartan Impurity 21 manufacturers
Telmisartan Impurity 21 price
Order Telmisartan Impurity 21
Enquire Telmisartan Impurity 21
Telmisartan Impurity 21 cost
Telmisartan Impurity 21 Supplier
Telmisartan Impurity 21 Distributor
Telmisartan Impurity 21 for Method Validation
Telmisartan Reference Standard
Telmisartan Impurity 21 for ANDA Filing
Telmisartan Impurity 21 for Forced Degradation Studies
Telmisartan Impurity 21 Identification Standards
Telmisartan Impurity 21 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.